Explore how generic drug competitors enter the market after the first approval. We analyze the 180-day exclusivity, price erosion patterns, authorized generics, and the impact of PBMs on drug costs and availability.
Tag: authorized generics
Explore the legal clash between 180-day generic exclusivity and authorized generics. Learn how brand-name drugs bypass regulations, impacting market share and patent litigation strategies in the US pharma industry.
Authorized generics offer the exact same medication as brand-name drugs at lower prices - with no changes to ingredients. Learn how they can prevent side effects when switching from brand to generic.
Authorized generics and first-to-file generics both lower drug costs, but authorized generics drive prices down further by adding competition during the first-filer's exclusivity period - saving patients and insurers millions.